Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

ClinicalTrials.gov ID: NCT02669433

Public ClinicalTrials.gov record NCT02669433. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 5:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Double-Blind, Randomized, Placebo-Controlled Study of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study seeks to evaluate the efficacy and safety of intepirdine (RVT-101) in patients with dementia with Lewy bodies.

Study identification

NCT ID
NCT02669433
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Axovant Sciences Ltd.
Industry
Enrollment
484 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2016 (Actual)
Primary completion
Dec 2017 (Actual)
Completion
Dec 2017 (Actual)
Last update posted
Apr 26, 2019

2016 – 2017

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
29
Facility City State ZIP Site status
US138 Phoenix Arizona 85006 —
US108 Phoenix Arizona 85013 —
US139 Sun City Arizona 85351 —
US125 Tucson Arizona 85704 —
US119 Irvine California 92868 —
US134 Oxnard California 93030 —
US133 Rancho Mirage California 92270 —
US140 Sacramento California 95816 —
US141 Englewood Colorado 80113 —
US123 Washington D.C. District of Columbia 20007 —
US104 Boca Raton Florida 33431 —
US116 Boca Raton Florida 33486 —
US111 Jacksonville Florida 32224 —
US122 Orlando Florida 32806 —
US137 Palm Beach Gardens Florida 33410 —
US126 Tampa Florida 33609 —
US136 Atlanta Georgia 30331 —
US112 Chicago Illinois 60612 —
US118 Indianapolis Indiana 46202 —
US105 Lexington Kentucky 40536 —
US135 Newton Massachusetts 02459 —
US130 Quincy Massachusetts 02196 —
US102 Rochester Minnesota 55905 —
US109 New York New York 10032 —
US100 Chapel Hill North Carolina 27514 —
US110 Cleveland Ohio 44195 —
US106 Columbus Ohio 43210 —
US131 Portland Oregon 97210 —
US120 Willow Grove Pennsylvania 19090 —
US124 Dallas Texas 75390 —
US101 Charlottesville Virginia 22908 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02669433, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2019 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02669433 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →